Juan Graham

KYNB

Juan Graham serves as Chief Financial Officer at Kyntra Bio, Inc. (KYNB). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$74.9K

Total Sells

4 trades

$305.2K

Net Position

Net Seller

$230.3K

Companies Traded

CATX, KYNB

Active Period

Dec 2022 – Mar 2025

5 total trades

Most Recent

Buy CATX

Mar 28, 2025 · $74.9K

Juan Graham's Insider Trading at Kyntra Bio, Inc. (KYNB)

Buys

0 · $0.00

Sells

4 · $305.2K

Total Shares Bought

Total Shares Sold

17,375

KYNB Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 9, 2023	Sell	1,785	$16.99	$30.3K	71,818
Mar 10, 2023	Sell	7,661	$20.54	$157.4K	76,668
Dec 15, 2022	Sell	5,741	$14.89	$85.5K	50,628
Dec 14, 2022	Sell	2,188	$14.64	$32.0K	55,110

Juan Graham's Insider Trading at Perspective Therapeutics, Inc. (CATX)

Buys

1 · $74.9K

Sells

0 · $0.00

Total Shares Bought

33,333

Total Shares Sold

CATX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 28, 2025	Buy	33,333	$2.25	$74.9K	0

Related Insiders

Lantheus Alpha Therapy, LLC

10 percent owner

CATXSell · Sep 8, 2026

Lantheus Holdings, Inc.

10 percent owner

CATXSell · Sep 3, 2026

Thane Wettig

director, officer: CEO

KYNBBuy · May 18, 2026

David DeLucia

Chief Financial Officer

KYNBSell · Dec 6, 2025

Jonathan Robert Hunt

Chief Accounting Officer

CATXBuy · Nov 13, 2025

Robert F Williamson III

Director

CATXBuy · Nov 12, 2025

Explore More Insider Trading Data

KYNB Insider Trading Activity

View all insider trades at Kyntra Bio, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity